Purpose

The purpose of this study is to learn about the effectiveness of different pain control options after hand and wrist surgery, specifically Ketorolac, Tylenol, and a regional nerve block. Ketorolac (Toradol) is a nonsteroidal anti-inflammatory drug (NSAID) that is similar to ibuprofen (Motrin or Advil). Tylenol (acetaminophen) is a commonly used over the counter drug. A nerve block is pain medication that is applied directly to the nerves around the surgical site before the surgery and keeps working to reduce pain in the area for several hours after the surgery. All of these medicines and procedures are approved by the Food and Drug Administration (FDA) for patient care. This study aims to understand if using these medicines in combination helps patients having hand and wrist surgery avoid the need for opioid pain medications.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Age 18 years or older 2. Undergoing upper extremity surgery performed by a hand and upper extremity orthopaedic surgeon at the University of Chicago. 3. Undergoing procedure with regional nerve block

Exclusion Criteria

  1. Age less than 18 years 2. Concomitant chronic opioid use 3. Postoperative opioid use (surgery through POD 14) for condition other than repaired fracture 4. Medical contraindication to ketorolac use, including pregnancy 5. Undergoing multiple concurrent surgical procedures 6. Unable to communicate numerical pain score

Study Design

Phase
Phase 4
Study Type
Interventional
Allocation
Non-Randomized
Intervention Model
Sequential Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Non-Opioid
Regional Nerve Block + Ketorolac (Toradol) + Tylenol (acetaminophen)
  • Drug: Toradol
    Regional Nerve Block + Toradol + Acetaminophen
Active Comparator
Opioid
Regional Nerve Block + Oxycodone (5mg, 10 tablets) + Tylenol (acetaminophen)
  • Drug: Toradol
    Regional Nerve Block + Toradol + Acetaminophen
  • Drug: Oxycodone
    Regional Nerve Block + Oxycodone + Acetaminophen

Recruiting Locations

University of Chicago
Chicago, Illinois 60637

More Details

Status
Recruiting
Sponsor
University of Chicago

Study Contact

Jennifer Wolf, MD
773-795-3583
jwolf@bsd.uchicago.edu

Detailed Description

Participants will be enrolled in two sequential groups: - The first group will be consented for a post-operative pain control regimen consisting of an intraoperative regional nerve block and 3 days of round-the-clock oral ketorolac, plus prescription strength acetaminophen as needed. These analgesic elements are standard of care for patients undergoing the procedures of interest, as an alternative to opioid use, though subjects of this study will be asked to use them as first-line therapy and receive other medications only for breakthrough pain. - The second group will be consented for a post-operative pain control regimen consisting of a standard care regimen of intraoperative regional nerve block and 3 days of round-the-clock opioids. Patients in both groups will be asked to complete surveys in which they rate their pain score and describe what medications they have taken for pain.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.